Cargando…

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?

Detalles Bibliográficos
Autor principal:	Kumar, Arun H. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934097/ https://www.ncbi.nlm.nih.gov/pubmed/27433058 http://dx.doi.org/10.4103/0976-9668.184694

Ejemplares similares

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Long, Sydney B, et al.
Publicado: (2011)

Statins in primary prevention: is the enthusiasm justified?
por: Chopra, Arun K., et al.
Publicado: (2020)

A Case of Statin-Induced Interstitial Pneumonitis due to Rosuvastatin
por: Kim, Se Yong, et al.
Publicado: (2015)

Personalized rosuvastatin therapy in problem patients with partial statin intolerance
por: Shek, Aleksandr B., et al.
Publicado: (2018)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
por: Ward, Michael M
Publicado: (2009)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
por: Clough, Jeffrey D., et al.
Publicado: (2019)

The use of statins in primary prevention
por: Rosian, Ingrid, et al.
Publicado: (2006)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

State of The Globe: Antimicrobial Resistance: Are we Ready?
por: Raina, Sunil Kumar
Publicado: (2019)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Statins in COVID-19: A new ray of hope
por: Kunal, Shekhar, et al.
Publicado: (2020)

Statins and prostate cancer—hype or hope? The epidemiological perspective
por: Craig, Emma L., et al.
Publicado: (2022)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
por: Strandberg, Timo E.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

The effect of statins on the organs: similar or contradictory?
por: Ahmadi, Yasin, et al.
Publicado: (2017)

Statins: are they appropriate for all patients?
por: Raal, Frederick J, et al.
Publicado: (2022)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
por: Fleetcroft, Robert, et al.
Publicado: (2014)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

To JUPITER and beyond: Statins, inflammation, and primary prevention
por: Rao, Ajay D, et al.
Publicado: (2010)

Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019)

Statin intensity and risk for cardiovascular events after heart transplantation
por: Golbus, Jessica R., et al.
Publicado: (2020)

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
por: Thompson, Wade, et al.
Publicado: (2021)

Statin use and incident cardiovascular events in renal transplant recipients
por: Anderson, Josephine L. C., et al.
Publicado: (2021)

Rosuvastatin-Induced Dizziness and Pruritus: A Case Report and Summary of Statin-Associated Dizziness and Pruritus
por: Malik, Sara, et al.
Publicado: (2022)

High-Intensity Statin With Severe Consequences: A Case of Non-autoimmune Rosuvastatin-Induced Myonecrosis
por: Hassan, Mariam, et al.
Publicado: (2022)

Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial
por: Camilleri, Eleonora, et al.
Publicado: (2023)

Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Age-Based Disparities in Guideline-Recommended Statin Initiation for Primary Prevention Among Statin-Naive Adults
por: Zheutlin, Alexander R., et al.
Publicado: (2023)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”
por: Diamond, David M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7fklpbnfd3got57e5o7258uem2